The Stone Center Acquires Powerful New Prostate Cancer Targeting Tool

NEWARK, NJ – The Stone Center, one of the largest lithotripsy centers in the United States, announced that it is expanding its urological services for patients through the acquisition of a powerful new tool for the analysis, planning and targeted biopsy of the prostate. The new technology, available in New Jersey only at The Stone Center, is known as the “UroNav fusion biopsy system” and clinicians have found that it is better able to pinpoint trouble spots and lead to a quicker prostate cancer diagnosis.